PRESS RELEASE published on 04/08/2025 at 08:00, 1 year 6 months ago Quantum Genomics provides an update on its situation Quantum Genomics provides an update on trading suspension, search for a new business partner, and financial situation with impending yearly accounts release Financial Situation Trading Suspension Quantum Genomics Reverse Take Over Yearly Accounts Release
PRESS RELEASE published on 04/08/2025 at 08:00, 1 year 6 months ago Ondine Biomedical Inc. Announces Steriwave in First Swiss Hospital University Hospital Zurich conducts independent study on Steriwave for preoperative nasal decolonization, assessing efficacy in reducing microbial burden to combat surgical site infections (SSI) Nasal Decolonization Steriwave Clinical Study University Hospital Zurich Antimicrobial Photodynamic Therapy
PRESS RELEASE published on 04/08/2025 at 07:46, 1 year 6 months ago INFORMATIONS PRIVILÉGIÉES / AUTRES COMMUNIQUÉS GenSight Biologics met à disposition son Document d'Enregistrement Universel 2024 pour consultation en ligne Document D'Enregistrement Universel GenSight Biologics Thérapies Géniques Maladies Neurodégénératives Rétine
REGULATED PRESS RELEASE published on 04/08/2025 at 07:45, 1 year 6 months ago COGRA : RAPPORT FINANCIER SEMESTRIEL 2024/2025
REGULATED PRESS RELEASE published on 04/08/2025 at 07:45, 1 year 6 months ago COGRA : CHIFFRE D’AFFAIRES DU 3ème TRIMESTRE 2024/25 : 11,5 M€ Cogra annonce un chiffre d'affaires de 11,5 M€ au 3ème trimestre 2024/25, marquant un rebond de +49% avec la normalisation du marché. Perspectives de croissance rentable dans le secteur de l'énergie bois Chiffre D'affaires Croissance Cogra Énergie Bois Marché Normalisé
PRESS RELEASE published on 04/08/2025 at 07:43, 1 year 6 months ago INSIDE INFORMATION / OTHER NEWS RELEASES GenSight Biologics announces the filing of its 2024 Universal Registration Document with the French market authority, including financial reports and corporate governance details GenSight Biologics Gene Therapies Retinal Neurodegenerative Diseases 2024 Universal Registration Document Central Nervous System Disorders
PRESS RELEASE published on 04/08/2025 at 07:30, 1 year 6 months ago Informations privilégiées / Autres communiqués Fill Up Média obtient le label 'DOOH Trust' de l'ACPM, garantissant transparence et fiabilité des campagnes publicitaires. La régie renforce son offre avec cette certification Certification Fill Up Media Campagnes Publicitaires DOOH Trust ACPM
PRESS RELEASE published on 04/08/2025 at 07:30, 1 year 6 months ago Inside Information / Other news releases MaaT Pharma announces positive safety interim analysis from DSMB for Phase 2b trial evaluating MaaT033 for patients receiving Allo-HSCT, demonstrating favorable safety profile and tolerability Phase 2B Trial MaaT Pharma Safety Analysis MaaT033 Allo-HSCT
PRESS RELEASE published on 04/08/2025 at 07:30, 1 year 6 months ago Informations privilégiées / Autres communiqués MaaT Pharma annonce résultat positif analyse intermédiaire sécurité essai clinique Phase 2b MaaT033 allo-GCSH. DSMB recommande poursuite essai sans modification Sécurité DSMB MaaT Pharma Analyse Intermédiaire Allo-GCSH
PRESS RELEASE published on 04/08/2025 at 07:00, 1 year 6 months ago BIOVERSYS TO PRESENT BV100 PHASE 2 DATA AT 35TH ESCMID GLOBAL 2025 BioVersys to present BV100 Phase 2 data at 35th ESCMID Global 2025. Oral presentation on positive VABP trial read-out & poster presentations on Acinetobacter baumannii & NTM data Clinical Data BV100 Antibacterial Products BioVersys ESCMID Global 2025
Published on 10/23/2026 at 02:20, 14 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 3 hours 4 minutes ago Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 4 hours 4 minutes ago Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 10 hours 34 minutes ago Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 12 hours 4 minutes ago Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Published on 10/23/2026 at 01:55, 38 minutes ago Guardian. For Family｜TIGGO7 Crash Test Results Demonstrate CHERY's Commitment to Family Safety
Published on 10/22/2026 at 22:10, 4 hours 23 minutes ago Quantinuum to Report Third Quarter Financial Results on November 5, 2026
Published on 10/22/2026 at 20:00, 6 hours 34 minutes ago Exchange offer for Eleving Group 2023/2028 bonds (ISIN DE000A3LL7M4) completed
Published on 10/22/2026 at 19:45, 6 hours 49 minutes ago EUROPLASMA: Les Forges de Tarbes sollicitent l’ouverture d’une procédure de redressement judiciaire
Published on 10/22/2026 at 18:45, 7 hours 48 minutes ago Swedish Export Credit Corporation (SEK): Europe's defence build-up opens opportunities for Swedish companies in Germany
Published on 10/22/2026 at 18:00, 8 hours 34 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 8 hours 34 minutes ago THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 8 hours 34 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 8 hours 34 minutes ago bioMérieux obtient l’autorisation 510(k) et la dérogation CLIA de la FDA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel : une avancée pour améliorer la santé des femmes grâce au diagnostic moléculaire rapide
Published on 10/22/2026 at 18:00, 8 hours 34 minutes ago 1er semestre 2026 : résultats opérationnels en nette amélioration
